Column Group IV, LP is Director & 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM). They have made 4 open-market trades across 1 company since 2022, most recently 2024-12-23.
CIK 0001796354
4 open-market purchases totalling $1.3M since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NGM | 380,172 | $585K |
Shares reported on the most recent Form 4, priced at the 2022-11-23 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.